Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Göran, Lundell"'
Autor:
Marie Hjälm-Eriksson, Hemming Johansson, Enrique Castellanos, Göran Lundell, Yvonne Brandberg, Bo Lennernäs, Sten Nilsson, Anders Ullén
Publikováno v:
Acta Oncologica. 60:1301-1307
BACKGROUND AND PURPOSE To analyse the cumulative incidence of any failure (AF), prostate cancer-specific failure (PCSF), any death (AD), prostate cancer-specific death (PCSD), and local control in 2387 men with prostate cancer (PC), consecutively tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57514e9cf925d76c46523fa70496133b
https://doi.org/10.1080/0284186x.2021.1953706
https://doi.org/10.1080/0284186x.2021.1953706
Autor:
Mirna Abraham-Nordling, Göran Wallin, Frank Träisk, Gertrud Berg, Jan Calissendorff, Bengt Hallengren, Pavo Hedner, Mikael Lantz, Ernst Nyström, Peter Åsman, Göran Lundell, Ove Törring
Publikováno v:
European Journal of Endocrinology. 163:651-657
ObjectiveThe objective of this study was to investigate quality of life (QoL) in patients with Graves' disease treated with radioiodine or antithyroid drugs.Design and methodsThe design of the study consists of an open, prospective, randomized multic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c47a9396d92ec85f90969a957069175
https://doi.org/10.1530/eje-10-0475
https://doi.org/10.1530/eje-10-0475
Autor:
Frank, Träisk, Leif, Tallstedt, Mirna, Abraham-Nordling, Tommy, Andersson, Gertrud, Berg, Jan, Calissendorff, Bengt, Hallengren, Pavo, Hedner, Mikael, Lantz, Ernst, Nyström, Vesna, Ponjavic, Adam, Taube, Ove, Törring, Göran, Wallin, Peter, Asman, Göran, Lundell, H, Blomgren
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 94:3700-3707
Previous randomized trials have suggested an association between radioiodine treatment for Graves' hyperthyroidism and thyroid-associated ophthalmopathy (TAO).The aim of the study was to compare the occurrence of worsening or development of TAO in pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e70e65261ae620970ef35cdf710bfefd
https://doi.org/10.1210/jc.2009-0747
https://doi.org/10.1210/jc.2009-0747
Publikováno v:
Acta Ophthalmologica Scandinavica. 75:11-16
The Swedish experience of ruthenium 106 plaque radiotherapy for posterior uveal melanoma includes 266 patients treated between 1979 and 1995. The median dose delivered at the tumour apex was 100 Gy and the median follow-up after radiotherapy was 3.6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e7b7d9932783b448976898135be5c24
https://doi.org/10.1111/j.1600-0420.1997.tb00241.x
https://doi.org/10.1111/j.1600-0420.1997.tb00241.x
Publikováno v:
Acta Ophthalmologica Scandinavica. 75:148-154
Enucleation following ruthenium plaque radiotherapy for posterior uveal melanoma indicates failure of treatment. This study focused on the histopathological findings and remaining tumour cell growth fraction in 42 of 46 patients with failed ruthenium
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::733a81c0e4eb01540288dc6c1ee2bb40
https://doi.org/10.1111/j.1600-0420.1997.tb00112.x
https://doi.org/10.1111/j.1600-0420.1997.tb00112.x
Publikováno v:
European Journal of Endocrinology. 156:173-179
Objective: In a 14–21 year follow-up of health-related quality of life (HRQL) outcome of 179 patients after randomized treatment of Graves’ disease (GD) with surgical, medical or radioiodine, we found no differences. The HRQL for Graves’ patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5b092f567cffbebb5e698d69b71c499
https://doi.org/10.1530/eje.1.02336
https://doi.org/10.1530/eje.1.02336
Autor:
Catharina Larsson, Jan Zedenius, Martin Bäckdahl, Bertil Hamberger, Lars-Ove Farnebo, P. Kjellman, Göran Lundell, Göran Wallin
Publikováno v:
European Journal of Surgical Oncology (EJSO). 32:345-352
Aim of the study To evaluate prognostic factors with respect to the outcome in a consecutive series of patients with papillary thyroid carcinoma (PTC) treated at the same institution during a 20-year-period, and to evaluate further the predictive abi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdf308f591dff174960d7db9ac7f9f37
https://doi.org/10.1016/j.ejso.2005.12.008
https://doi.org/10.1016/j.ejso.2005.12.008
Autor:
Göran Wallin, Bertil Hamberger, Mirna Abraham-Nordling, Ove Tørring, Leif Tallstedt, Jan Calissendorff, Göran Lundell
Publikováno v:
Thyroid. 15:1279-1286
The effects of treatment modality for Graves' disease (GD) were studied with respect to long-term quality of life and present health status. A total of 179 patients with GD were randomized during the period 1983-1990 for treatment with antithyroid dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee557461860bfbaf937f70932f1eee31
https://doi.org/10.1089/thy.2005.15.1279
https://doi.org/10.1089/thy.2005.15.1279
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 60:395-400
To determine the long-term incidence of postirradiation hypothyroidism (HT) in patients with head-and-neck cancer.The incidence of overt HT was assessed prospectively in 391 patients with nonthyroid head-and-neck cancer admitted for radiotherapy (RT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd0888e3efec15ba7fcf6faf3f919de1
https://doi.org/10.1016/j.ijrobp.2004.03.020
https://doi.org/10.1016/j.ijrobp.2004.03.020